Article
Predictive biomarkers investigated in glioblastoma
5 Aug 2014
Abstract excerpt
Glioblastoma is the most aggressive primary brain tumor in adults. Consequently, new therapeutic strategies are needed. Tumor response to cytotoxic chemotherapy is heterogeneous across patients. Interestingly, predictive biomarkers of response to these classic chemotherapeutic agents have been identified in neuro-oncology (i.e., 1p/19q co-deletion, IDH mutation and O6-methylguanine DNA-methyltransferase promoter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
